Cardiac sodium channel Nav1.5 and interacting proteins: Physiology and pathophysiology

Journal of Molecular and Cellular Cardiology

Volumn 48, Issue 1, 2010, Pages 2-11

  Abriel, Hugues ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 SYNTROPHIN; ANKYRIN; ANKYRIN G; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALMODULIN; CAVEOLIN 3; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR HOMOLOGOUS 1B; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; PLAKOPHILIN; PLAKOPHILIN 2; PROTEIN; PROTEIN 14 3 3; PROTEIN 14 3 3 ETA; PROTEIN MOG1; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 1; SODIUM CHANNEL NAV1.5; SODIUM CHANNEL NAV1.5 BETA SUBUNIT; SODIUM CHANNEL NAV1.5 BETA1 SUBUNIT; SODIUM CHANNEL NAV1.5 BETA1B SUBUNIT; SODIUM CHANNEL NAV1.5 BETA2 SUBUNIT; SODIUM CHANNEL NAV1.5 BETA3 SUBUNIT; SODIUM CHANNEL NAV1.5 BETA4 SUBUNIT; SYNTROPHIN; TELETHONIN; UBIQUITIN PROTEIN LIGASE NEDD4; UNCLASSIFIED DRUG; VOLTAGE GATED SODIUM CHANNEL;

AMINO ACID SEQUENCE; BRUGADA SYNDROME; BRUGADA SYNDROME TYPE 2; BRUGADA SYNDROME TYPE 5; BRUGADA SYNDROME TYPE 7; CARDIAC CHANNELOPATHY; GENE EXPRESSION; GENE MUTATION; HUMAN; LONG QT SYNDROME; LONG QT SYNDROME TYPE 10; LONG QT SYNDROME TYPE 12; LONG QT SYNDROME TYPE 9; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW;

ANIMALS; ARRHYTHMIAS, CARDIAC; HEART; HUMANS; MUSCLE PROTEINS; MUTATION; MYOCARDIUM; PROTEIN BINDING; PROTEINS; SODIUM CHANNELS;

EID: 73049097840     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.08.025     Document Type: Review

References (145)

1. Grant A.O. Cardiac ion channels. Circ. Arrhythmia Electrophysiol. 2 (2009) 185-194
2. Weidmann S. The effect of the cardiac membrane potential on the rapid availability of the sodium-carrying system. J. Physiol. 127 (1955) 213-224
3. Fozzard H.A. Cardiac sodium and calcium channels: a history of excitatory currents. Cardiovasc. Res. 55 (2002) 1-8
4. Makielski J.C., Ye B., Valdivia C.R., Pagel M.D., Pu J., Tester D.J., et al. A ubiquitous splice variant and a common polymorphism affect heterologous expression of recombinant human SCN5A heart sodium channels. Circ. Res. 93 (2003) 821-828
5. Meadows L.S., and Isom L.L. Sodium channels as macromolecular complexes: implications for inherited arrhythmia syndromes. Cardiovasc. Res. 67 (2005) 448-458
6. Zimmer T., and Surber R. SCN5A channelopathies-an update on mutations and mechanisms. Prog. Biophys. Mol. Biol. 98 (2008) 120-136
7. Goldenberg I., Zareba W., and Moss A.J. Long QT syndrome. Curr. Probl. Cardiol. 33 (2008) 629-694
8. Hedley P.L., Jorgensen P., Schlamowitz S., Moolman-Smook J., Kanters J.K., Corfield V.A., et al. The genetic basis of Brugada syndrome: a mutation update. Hum. Mutat. (2009)
9. Abriel H., and Kass R.S. Regulation of the voltage-gated cardiac sodium channel Nav1.5 by interacting proteins. Trends Cardiovasc. Med. 15 (2005) 35-40
10. Mohler P.J., Rivolta I., Napolitano C., Lemaillet G., Lambert S., Priori S.G., et al. Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 17533-17538
11. Liu C.J., Dib-Hajj S.D., Renganathan M., Cummins T.R., and Waxman S.G. Modulation of the cardiac sodium channel Nav1.5 by fibroblast growth factor homologous factor 1B. J. Biol. Chem. 278 (2003) 1029-1036
12. Deschenes I., Neyroud N., DiSilvestre D., Marban E., Yue D.T., and Tomaselli G.F. Isoform-specific modulation of voltage-gated Na(+) channels by calmodulin. Circ. Res. 90 (2002) E49-E57
13. van Bemmelen M.X., Rougier J.S., Gavillet B., Apotheloz F., Daidie D., Tateyama M., et al. Cardiac voltage-gated sodium channel Nav1.5 is regulated by Nedd4-2 mediated ubiquitination. Circ. Res. 95 (2004) 284-291
14. Rougier J.S., van Bemmelen M.X., Bruce M.C., Jespersen T., Gavillet B., Apotheloz F., et al. Molecular determinants of voltage-gated sodium channel regulation by the Nedd4/Nedd4-like proteins. Am. J. Physiol., Cell Physiol. 288 (2005) C692-C701
15. Gee S.H., Madhavan R., Levinson S.R., Caldwell J.H., Sealock R., and Froehner S.C. Interaction of muscle and brain sodium channels with multiple members of the syntrophin family of dystrophin-associated proteins. J. Neurosci. 18 (1998) 128-137
16. Gavillet B., Rougier J.S., Domenighetti A.A., Behar R., Boixel C., Ruchat P., et al. Cardiac sodium channel Nav1.5 is regulated by a multiprotein complex composed of syntrophins and dystrophin. Circ. Res. 18 (2006) 407-414
17. Glickman M.H., and Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol. Rev. 82 (2002) 373-428
18. Staub O., and Rotin D. Role of ubiquitylation in cellular membrane transport. Physiol. Rev. 86 (2006) 669-707
19. Hershko A., and Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 67 (1998) 425-479
20. Hicke L., and Dunn R. Regulation of membrane protein transport by ubiquitin and ubiquitin-binding proteins. Annu. Rev. Cell Dev. Biol. 19 (2003) 141-172
21. Abriel H., and Staub O. Ubiquitylation of ion channels. Physiology 20 (2005) 398-407
22. Rotin D., and Kumar S. Physiological functions of the HECT family of ubiquitin ligases. Nat. Rev., Mol. Cell Biol. 10 (2009) 398-409
23. Fotia A.B., Ekberg J., Adams D.J., Cook D.I., Poronnik P., and Kumar S. Regulation of neuronal voltage-gated sodium channels by the ubiquitin-protein ligases Nedd4 and Nedd4-2. J. Biol. Chem. 279 (2004) 28930-28935
24. Jespersen T., Membrez M., Nicolas C.S., Pitard B., Staub O., Olesen S.P., et al. The KCNQ1 potassium channel is down-regulated by ubiquitylating enzymes of the Nedd4/Nedd4like family. Cardiovasc. Res. 74 (2007) 64-74
25. Staub O., and Rotin D. WW domains. Structure 4 (1996) 495-499
26. Abriel H., Kamynina E., Horisberger J.D., and Staub O. Regulation of the cardiac voltage-gated Na+ channel (H1) by the ubiquitin-protein ligase Nedd4. FEBS Lett. 466 (2000) 377-380
27. Kang L., Zheng M., Morishima M., Wang Y., Kaku T., and Ono K. Bepridil up-regulates cardiac Na(+) channels as a long-term effect by blunting proteasome signals through inhibition of calmodulin activity. Br. J. Pharmacol. (2009)
28. Ingham R.J., Gish G., and Pawson T. The Nedd4 family of E3 ubiquitin ligases: functional diversity within a common modular architecture. Oncogene 23 (2004) 1972-1984
29. Morrison D.K. The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol. 19 (2009) 16-23
30. Mrowiec T., and Schwappach B. 14-3-3 proteins in membrane protein transport. Biol. Chem. 387 (2006) 1227-1236
31. Allouis M., Le Bouffant F., Wilders R., Peroz D., Schott J.J., Noireaud, et al. 14-3-3 is a regulator of the cardiac voltage-gated sodium channel Nav1.5. Circ. Res. 98 (2006) 1538-1546
32. Liu C.J., Dib-Hajj S.D., and Waxman S.G. Fibroblast growth factor homologous factor 1B binds to the C terminus of the tetrodotoxin-resistant sodium channel rNav1.9a (NaN). J. Biol. Chem. 276 (2001) 18925-18933
33. Olsen S.K., Garbi M., Zampieri N., Eliseenkova A.V., Ornitz D.M., Goldfarb M., et al. Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs. J. Biol. Chem. 278 (2003) 34226-34236
34. Goetz R., Dover K., Laezza F., Shtraizent N., Huang X., Tchetchik D., et al. Crystal structure of a fibroblast growth factor homologous factor (FHF) defines a conserved surface on FHFS for binding and modulation of voltage-gated sodium channels. J. Biol. Chem. 284 (2009) 17883-17896
35. Wehrens X.H.T., Abriel H., Cabo C., Benhorin J., and Kass R.S. Arrhythmogenic mechanism of an LQT-3 mutation of the human heart Na(+) channel alpha-subunit: a computational analysis. Circulation 102 (2000) 584-590
36. Lou J.Y., Laezza F., Gerber B.R., Xiao M., Yamada K.A., Hartmann H., et al. Fibroblast growth factor 14 is an intracellular modulator of voltage-gated sodium channels. J. Physiol. 569 (2005) 179-193
37. Chin D., and Means A.R. Calmodulin: a prototypical calcium sensor. Trends Cell Biol. 10 (2000) 322-328
38. Saimi Y., and Kung C. Calmodulin as an ion channel subunit. Annu. Rev. Physiol. 64 (2002) 289-311
39. Pitt G.S. Calmodulin and CaMKII as molecular switches for cardiac ion channels. Cardiovasc. Res. 73 (2007) 641-647
40. Herzog R.I., Liu C., Waxman S.G., and Cummins T.R. Calmodulin binds to the C terminus of sodium channels Nav1.4 and Nav1.6 and differentially modulates their functional properties. J. Neurosci. 23 (2003) 8261-8270
41. Tan H.L., Kupershmidt S., Zhang R., Stepanovic S., Roden D.M., Wilde A.A., et al. A calcium sensor in the sodium channel modulates cardiac excitability. Nature 415 (2002) 442-447
42. Kim J., Ghosh S., Liu H., Tateyama M., Kass R.S., and Pitt G.S. Calmodulin mediates Ca2+ sensitivity of sodium channels. J. Biol. Chem. 279 (2004) 45004-45012
43. Young K.A., and Caldwell J.H. Modulation of skeletal and cardiac voltage-gated sodium channels by calmodulin. J. Physiol. 565 (2005) 349-370
44. Motoike H.K., Liu H., Glaaser I.W., Yang A.S., Tateyama M., and Kass R.S. The Na+ channel inactivation gate is a molecular complex: a novel role of the COOH-terminal domain. J. Gen. Physiol. 123 (2004) 155-165
45. Shah V.N., Wingo T.L., Weiss K.L., Williams C.K., Balser J.R., and Chazin W.J. Calcium-dependent regulation of the voltage-gated sodium channel hH1: intrinsic and extrinsic sensors use a common molecular switch. Proc. Natl. Acad. Sci. 103 (2006) 3592-3597
46. Wingo T.L., Shah V.N., Anderson M.E., Lybrand T.P., Chazin W.J., and Balser J.R. An EF-hand in the sodium channel couples intracellular calcium to cardiac excitability. Nat. Struct. Mol. Biol. 11 (2004) 219-225
47. Potet F., Chagot B., Anghelescu M., Viswanathan P.C., Stepanovic S.Z., Kupershmidt S., et al. Functional interactions between distinct sodium channel cytoplasmic domains through the action of calmodulin. J. Biol. Chem. 284 (2009) 8846-8854
48. Chagot B., Potet F., Balser J.R., and Chazin W.J. Solution NMR structure of the C-terminal EF-hand domain of human cardiac sodium channel NaV1.5. J. Biol. Chem. 284 (2008) 6436-6445
49. Miloushev V.Z., Levine J.A., Arbing M.A., Hunt J.F., Pitt G.S., and Palmer III A.G. Solution structure of the NaV1.2 C-terminal EF-hand domain. J. Biol. Chem. 284 (2009) 6446-6454
50. Casini S., Verkerk A.O., van Borren M.M., van Ginneken A.C., Veldkamp M.W., de Bakker J.M., et al. Intracellular calcium modulation of voltage-gated sodium channels in ventricular myocytes. Cardiovasc. Res. 81 (2009) 72-81
51. Couchonnal L.F., and Anderson M.E. The role of calmodulin kinase II in myocardial physiology and disease. Physiology 23 (2008) 151-159
52. Maier L.S. Role of CaMKII for signaling and regulation in the heart. Front. Biosci. 14 (2009) 486-496
53. Maier L.S., and Bers D.M. Calcium, calmodulin, and calcium-calmodulin kinase II: heartbeat to heartbeat and beyond. J. Mol. Cell. Cardiol. 34 (2002) 919-939
54. Wagner S., Dybkova N., Rasenack E.C., Jacobshagen C., Fabritz L., Kirchhof P., et al. Ca/calmodulin-dependent protein kinase II regulates cardiac Na channels. J. Clin. Invest. 116 (2006) 3127-3128
55. Yoon J.Y., Ho W.K., Kim S.T., and Cho H. Constitutive CaMKII activity regulates Na+ channel in rat ventricular myocytes. J. Mol. Cell. Cardiol. 47 (2009) 475-484
56. Kass R.S. The channelopathies: novel insights into molecular and genetic mechanisms of human disease. J. Clin. Invest. 115 (2005) 1986-1989
57. Maltsev V.A., Reznikov V., Undrovinas N.A., Sabbah H.N., and Undrovinas A. Modulation of the late sodium current by Ca2+, calmodulin, and CaMKI I in normal and failing dog cardiomyocytes: similarities and differences. Am. J. Physiol.: Heart Circ. Physiol. 294 (2008) 1597-1608
58. Davis M.J., Wu X., Nurkiewicz T.R., Kawasaki J., Gui P., Hill M.A., et al. Regulation of ion channels by protein tyrosine phosphorylation. Am. J. Physiol.: Heart Circ. Physiol. 281 (2001) H1835-H1862
59. Ahern C.A., Zhang J.F., Wookalis M.J., and Horn R. Modulation of the cardiac sodium channel NaV1.5 by Fyn, a Src family tyrosine kinase. Circ. Res. 96 (2005) 991-998
60. Hartmann H.A., Tiedeman A.A., Chen S.F., Brown A.M., and Kirsch G.E. Effects of III-IV linker mutations on human heart Na+ channel inactivation gating. Circ. Res. 75 (1994) 114-122
61. Jespersen T., Gavillet B., van Bemmelen M.X., Cordonier S., Thomas M.A., Staub O., et al. Cardiac sodium channel Nav1.5 interacts with and is regulated by the protein tyrosine phosphatase PTPH1. Biochem. Biophys. Res. Commun. 348 (2006) 1456-1463
62. Faulkner G., Lanfranchi G., and Valle G. Telethonin and other new proteins of the Z-disc of skeletal muscle. IUBMB Life 51 (2001) 275-282
63. Hayashi T., Arimura T., Itoh-Satoh M., Ueda K., Hohda S., Inagaki N., et al. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J. Am. Coll. Cardiol. 44 (2004) 2192-2201
64. Mues A., van der Ven P.F.M., Young P., Furst D.O., and Gautel M. Two immunoglobulin-like domains of the Z-disc portion of titin interact in a conformation-dependent way with telethonin. FEBS Lett. 428 (1998) 111-114
65. Furukawa T., Ono Y., Tsuchiya H., Katayama Y., Bang M.L., Labeit D., et al. Specific interaction of the potassium channel beta-subunit minK with the sarcomeric protein T-cap suggests a T-tubule-myofibril linking system. J. Mol. Biol. 313 (2001) 775-784
66. Mazzone A., Strege P.R., Tester D.J., Bernard C.E., Faulkner G., DeGiorgio R., et al. A mutation in telethonin alters Nav1.5 function. J. Biol. Chem. 283 (2008) 16537-16544
67. Ou Y., Gibbons S.J., Miller S.M., Strege P.R., Rich A., Distad M.A., et al. SCN5A is expressed in human jejunal circular smooth muscle cells. Neurogastroenterol. Motil. 14 (2002) 477-486
68. Marfatia K.A., Harreman M.T., Fanara P., Vertino P.M., and Corbett A.H. Identification and characterization of the human MOG1 gene. Gene 266 (2001) 45-56
69. Wu L., Yong S.L., Fan C., Ni Y., Yoo S., Zhang T., et al. Identification of a new co-factor, MOG1, required for the function of cardiac sodium channel Nav1.5. J. Biol. Chem. 283 (2008) 6968-6978
70. Gerull B., Heuser A., Wichter T., Paul M., Basson C.T., McDermott D.A., et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat. Genet. 36 (2004) 1162-1164
71. Sato P.Y., Musa H., Coombs W., Guerrero-Serna G., Patino G.A., Taffet S.M., et al. Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes. Circ. Res. 105 (2009) 523-526
72. Oxford E.M., Musa H., Maass K., Coombs W., Taffet S.M., and Delmar M. Connexin43 remodeling caused by inhibition of plakophilin-2 expression in cardiac cells. Circ. Res. 101 (2007) 703-711
73. Williams T.M., and Lisanti M.P. The caveolin genes: from cell biology to medicine. Ann. Med. 36 (2004) 584-595
74. Vatta M., Ackerman M.J., Ye B., Makielski J.C., Ughanze E.E., Taylor E.W., et al. Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation 114 (2006) 2104-2112
75. Cronk L.B., Ye B., Kaku T., Tester D.J., Vatta M., Makielski J.C., et al. Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3. Heart Rhythm. 4 (2007) 161-166
76. Cohen A.W., Hnasko R., Schubert W., and Lisanti M.P. Role of caveolae and caveolins in health and disease. Physiol. Rev. 84 (2004) 1341-1379
77. Yarbrough T.L., Lu T., Lee H.C., and Shibata E.F. Localization of cardiac sodium channels in caveolin-rich membrane domains: regulation of sodium current amplitude. Circ. Res. 90 (2002) 443-449
78. Shibata E.F., Brown T.L., Washburn Z.W., Bai J., Revak T.J., and Butters C.A. Autonomic regulation of voltage-gated cardiac ion channels. J. Cardiovasc. Electrophysiol. 17 Suppl. 1 (2006) S34-S42
79. Doyle D.D., Goings G., Upshaw-Earley J., Ambler S.K., Mondul A., Palfrey H.C., et al. Dystrophin associates with caveolae of rat cardiac myocytes : relationship to dystroglycan. Circ. Res. 87 (2000) 480-488
80. Ueda K., Valdivia C., Medeiros-Domingo A., Tester D.J., Vatta M., Farrugia G., et al. Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex. Proc. Natl. Acad. Sci. 105 (2008) 9355-9360
81. Wu G., Ai T., Kim J.J., Mohapatra B., Xi Y., Li Z., et al. Alpha-1-syntrophin mutation and the long QT syndrome: a disease of sodium channel disruption. Circ. Arrhythmia Electrophysiol. 1 (2008) 193-201
82. Weiss R., Barmada M.M., Nguyen T., Seibel J.S., Cavlovich D., Kornblit C.A., et al. Clinical and molecular heterogeneity in the Brugada syndrome: a novel gene locus on chromosome 3. Circulation 105 (2002) 707-713
83. London B., Michalec M., Mehdi H., Zhu X., Kerchner L., Sanyal S., et al. Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias. Circulation 116 (2007) 2260-2268
84. Van Norstrand D.W., Valdivia C.R., Tester D.J., Ueda K., London B., Makielski J.C., et al. Molecular and functional characterization of novel glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) mutations in sudden infant death syndrome. Circulation 116 (2007) 2253-2259
85. Cunha S.R., and Mohler P.J. Cardiac ankyrins: essential components for development and maintenance of excitable membrane domains in heart. Cardiovasc. Res. 71 (2006) 22-29
86. Mohler P.J., Schott J.J., Gramolini A.O., Dilly K.W., Guatimosim S., DuBell W.H., et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 421 (2003) 634-639
87. Mohler P.J., Le Scouarnec S., Denjoy I., Lowe J.S., Guicheney P., Caron L., et al. Defining the cellular phenotype of "ankyrin-B syndrome" variants. Human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes. Circulation 115 (2007) 432-441
88. Chauhan V.S., Tuvia S., Buhusi M., Bennett V., and Grant A.O. Abnormal cardiac Na(+) channel properties and QT heart rate adaptation in neonatal ankyrin(B) knockout mice. Circ. Res. 86 (2000) 441-447
89. Lemaillet G., Walker B., and Lambert S. Identification of a conserved ankyrin-binding motif in the family of sodium channel alpha subunits. J. Biol. Chem. 278 (2003) 27333-27339
90. Lowe J.S., Palygin O., Bhasin N., Hund T.J., Boyden P.A., Shibata E., et al. Voltage-gated Nav channel targeting in the heart requires an ankyrin-G dependent cellular pathway. J. Cell Biol. 180 (2008) 173-186
91. Isom L.L. Sodium channel beta subunits: anything but auxiliary. Neuroscientist 7 (2001) 42-54
92. Qin N., D'Andrea M.R., Lubin M.L., Shafaee N., Codd E.E., and Correa A.M. Molecular cloning and functional expression of the human sodium channel beta1B subunit, a novel splicing variant of the beta1 subunit. Eur. J. Biochem. 270 (2003) 4762-4770
93. Qu Y., Isom L.L., Westenbroek R.E., Rogers J.C., Tanada T.N., McCormick K.A., et al. Modulation of cardiac Na+ channel expression in Xenopus oocytes by beta 1 subunits. J. Biol. Chem. 270 (1995) 25696-25701
94. Malhotra J.D., Chen C., Rivolta I., Abriel H., Malhotra R., Mattei L.N., et al. Characterization of sodium channel alpha- and beta-subunits in rat and mouse cardiac myocytes. Circulation 103 (2001) 1303-1310
95. McCormick K.A., Isom L.L., Ragsdale D., Smith D., Scheuer T., and Catterall W.A. Molecular determinants of Na+ channel function in the extracellular domain of the beta1 subunit. J. Biol. Chem. 273 (1998) 3954-3962
96. McCormick K.A., Srinivasan J., White K., Scheuer T., and Catterall W.A. The extracellular domain of the beta1 subunit is both necessary and sufficient for beta1-like modulation of sodium channel gating. J. Biol. Chem. 274 (1999) 32638-32646
97. Makita N., Bennett P.B., and George A.L.J. Molecular determinants of beta 1 subunit-induced gating modulation in voltage-dependent Na+ channels. J. Neurosci. 16 (1996) 7117-7127
98. Fahmi A.I., Patel M., Stevens E.B., Fowden A.L., John J.E., Lee K., et al. The sodium channel beta-subunit SCN3b modulates the kinetics of SCN5a and is expressed heterogeneously in sheep heart. J. Physiol. 537 (2001) 693-700
99. Bezzina C.R., Rook M.B., Groenewegen W.A., Herfst L.J., van der Wal A.C., Lam J., et al. Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system. Circ. Res. 92 (2003) 159-168
100. Kyndt F., Probst V., Potet F., Demolombe S., Chevallier J.C., Baro I., et al. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation 104 (2001) 3081-3086
101. Herfst L.J., Potet F., Bezzina C.R., Groenewegen W.A., Le Marec H., Hoorntje T.M., et al. Na+ channel mutation leading to loss of function and non-progressive cardiac conduction defects. J. Mol. Cell. Cardiol. 35 (2003) 549-557
102. Baroudi G., Carbonneau E., Pouliot V., and Chahine M. SCN5A mutation (T1620M) causing Brugada syndrome exhibits different phenotypes when expressed in Xenopus oocytes and mammalian cells. FEBS Lett. 467 (2000) 12-16
103. Valdivia C.R., Nagatomo T., and Makielski J.C. Late Na currents affected by alpha subunit isoform and beta 1 subunit co-expression in HEK293 cells. J. Mol. Cell. Cardiol. 34 (2002) 1029-1039
104. Maltsev V.A., Kyle J.W., and Undrovinas A. Late Na(+) current produced by human cardiac Na(+) channel isoform Na (v)1.5 is modulated by its beta (1) subunit. J. Physiol. Sci. 59 (2009) 217-225
105. Lopez-Santiago L.F., Meadows L.S., Ernst S.J., Chen C., Malhotra J.D., McEwen D.P., et al. Sodium channel Scn1b null mice exhibit prolonged QT and RR intervals. J. Mol. Cell. Cardiol. 43 (2007) 636-647
106. Watanabe H., Koopmann T.T., Le S.S., Yang T., Ingram C.R., Schott J.J., et al. Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J. Clin. Invest. 118 (2008) 2260-2268
107. Watanabe H., Darbar D., Kaiser D.W., Jiramongkolchai K., Chopra S., Donahue B.S., et al. Mutations in sodium channel beta1 and beta2 subunits associated with atrial fibrillation. Circ. Arrhythmia Electrophysiol. 2 (2009) 268-275
108. Remme C.A., Wilde A.A.M., and Bezzina C.R. Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations. Trends Cardiovasc. Med. 18 (2008) 78-87
109. Darbar D. Cardiac sodium channel variants: action players with many faces. Heart Rhythm. 5 (2008) 1441-1443
110. Zimmer T., Biskup C., Bollensdorff C., and Benndorf K. The beta1 subunit but not the beta2 subunit colocalizes with the human heart Na+ channel (hH1) already within the endoplasmic reticulum. J. Membr. Biol. 186 (2002) 13-21
111. Zimmer T., and Benndorf K. The human heart and rat brain IIA Na+ channels interact with different molecular regions of the beta(1) subunit. J. Gen. Physiol. 120 (2002) 887-895
112. Johnson D., and Bennett E.S. Isoform specific effects of the beta2 subunit on voltage-gated sodium channel gating. J. Biol. Chem. 281 (2006) 25875-25881
113. Ko S.H., Lenkowski P.W., Lee H.C., Mounsey J.P., and Patel M.K. Modulation of Na(v)1.5 by beta1- and beta3-subunit co-expression in mammalian cells. Pflugers Arch. 449 (2004) 403-412
114. Hakim P., Gurung I.S., Pedersen T.H., Thresher R., Brice N., Lawrence J., et al. Scn3b knockout mice exhibit abnormal ventricular electrophysiological properties. Prog. Biophys. Mol. Biol. 98 (2008) 251-266
115. Hu D., Barajas-Martinez H., Burashnikov E., Springer M., Wu Y., Varro A., et al. A mutation in the {beta}3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype. Circ. Cardiovasc. Genet. 2 (2009) 270-278
116. Yu F.H., Westenbroek R.E., Silos-Santiago I., McCormick K.A., Lawson D., Ge P., et al. Sodium channel beta4, a new disulfide-linked auxiliary subunit with similarity to beta2. J. Neurosci. 23 (2003) 7577-7585
117. Medeiros-Domingo A., Kaku T., Tester D.J., Iturralde-Torres P., Itty A., Ye B., et al. SCN4B-encoded sodium channel b4 subunit in congenital long-QT syndrome. Circulation 116 (2007) 134-142
118. Remme C.A., Scicluna B.P., Verkerk A.O., Amin A.S., van B.S., Beekman L., et al. Genetically determined differences in sodium current characteristics modulate conduction disease severity in mice with cardiac sodium channelopathy. Circ. Res. 104 (2009) 1283-1292
119. Remme C.A., Verkerk A.O., Nuyens D., van Ginneken A.C.G., van Brunschot S., Belterman C.N.W., et al. Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD. Circulation 114 (2006) 2584-2594
120. George Jr. A.L. Genetic modulation of impaired cardiac conduction: sodium channel {beta}4 subunit missing in action. Circ. Res. 104 (2009) 1238-1239
121. Napolitano C., Rivolta I., and Priori S.G. Cardiac sodium channel diseases. Clin. Chem. Lab. Med. 41 (2003) 439-444
122. Pettersson E., Lundeberg J., and Ahmadian A. Generations of sequencing technologies. Genomics 93 (2009) 105-111
123. Stevenson S.A., Cullen M.J., Rothery S., Coppen S.R., and Severs N.J. High-resolution en-face visualization of the cardiomyocyte plasma membrane reveals distinctive distributions of spectrin and dystrophin. Eur. J. Cell Biol. 84 (2005) 961-971
124. Singh A.K., Riederer B., Krabbenhoft A., Rausch B., Bonhagen J., Lehmann U., et al. Differential roles of NHERF1, NHERF2, and PDZK1 in regulating CFTR-mediated intestinal anion secretion in mice. J. Clin. Invest. 119 (2009) 540-550
125. Wang Q., Shen J., Splawski I., Atkinson D., Li Z., Robinson J.L., et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 80 (1995) 805-811
126. Tan H. Biophysical analysis of mutant sodium channels in Brugada syndrome. In: Antzelevitch C., Brugada P., Brugada J., and Brugada R. (Eds). The Brugada syndrome: from bench to bedside (2005), Blackwell Publishing 26-41
127. Chen Q., Kirsch G.E., Zhang D., Brugada R., Brugada J., Brugada P., et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 392 (1998) 293-296
128. Tan H.L., Bink-Boelkens M.T., Bezzina C.R., Viswanathan P.C., Beaufort-Krol G.C., van Tintelen P.J., et al. A sodium-channel mutation causes isolated cardiac conduction disease. Nature 409 (2001) 1043-1047
129. Schott J.J., Alshinawi C., Kyndt F., Probst V., Hoorntje T.M., Hulsbeek M., et al. Cardiac conduction defects associate with mutations in SCN5A. Nat. Genet. 23 (1999) 20-21
130. Wang D.W., Viswanathan P.C., Balser J.R., George Jr. A.L., and Benson D.W. Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block. Circulation 105 (2002) 341-346
131. Priori S.G., Napolitano C., Giordano U., Collisani G., and Memmi M. Brugada syndrome and sudden cardiac death in children. Lancet 355 (2000) 808-809
132. Wedekind H., Smits J.P., Schulze-Bahr E., Arnold R., Veldkamp M.W., Bajanowski T., et al. De novo mutation in the SCN5A gene associated with early onset of sudden infant death. Circulation 104 (2001) 1158-1164
133. Schwartz P.J., Priori S.G., Dumaine R., Napolitano C., Antzelevitch C., Stramba-Badiale M., et al. A molecular link between the sudden infant death syndrome and the long- QT syndrome. N. Engl. J. Med. 343 (2000) 262-267
134. Wang D.W., Desai R.R., Crotti L., Arnestad M., Insolia R., Pedrazzini M., et al. Cardiac sodium channel dysfunction in sudden infant death syndrome. Circulation 115 (2007) 368-376
135. Wang D.W., Crotti L., Shimizu W., Pedrazzini M., Cantu F., De Filippo P., et al. Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel. Circ. Arrhythmia Electrophysiol. 1 (2008) 370-378
136. Arnestad M., Crotti L., Rognum T.O., Insolia R., Pedrazzini M., Ferrandi C., et al. Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation 115 (2007) 361-367
137. Splawski I., Timothy K.W., Tateyama M., Clancy C.E., Malhotra A., Beggs A.H., et al. Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science 297 (2002) 1333-1336
138. Bezzina C.R., and Remme C.A. Dilated cardiomyopathy due to sodium channel dysfunction: what is the connection?. Circ. Arrhythmia Electrophysiol. 1 (2008) 80-82
139. McNair W.P., Ku L., Taylor M.R., Fain P.R., Dao D., Wolfel E., et al. SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation 110 (2004) 2163-2167
140. Olson T.M., Michels V.V., Ballew J.D., Reyna S.P., Karst M.L., Herron K.J., et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 293 (2005) 447-454
141. Shi R., Zhang Y., Yang C., Huang C., Zhou X., Qiang H., et al. The cardiac sodium channel mutation delQKP 1507-1509 is associated with the expanding phenotypic spectrum of LQT3, conduction disorder, dilated cardiomyopathy, and high incidence of youth sudden death. Europace 10 (2008) 1329-1335
142. Darbar D., Kannankeril P.J., Donahue B.S., Kucera G., Stubblefield T., Haines J.L., et al. Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation. Circulation 117 (2008) 1927-1935
143. Li Q., Huang H., Liu G., Lam K., Rutberg J., Green M.S., et al. Gain-of-function mutation of Na(v)1.5 in atrial fibrillation enhances cellular excitability and lowers the threshold for action potential firing. Biochem. Biophys. Res. Commun. 380 (2009) 132-137
144. Benson D.W., Wang D.W., Dyment M., Knilans T.K., Fish F.A., Strieper M.J., et al. Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J. Clin. Invest. 112 (2003) 1019-1028
145. Groenewegen W.A., Firouzi M., Bezzina C.R., Vliex S., Van Langen I.M., Sandkuijl L., et al. A cardiac sodium channel mutation cosegregates with a rare connexin40 genotype in familial atrial standstill. Circ. Res. 92 (2003) 14-22